ID	gene_id	CHROM	POS	REF	ALT	QUAL	FILTER	PRECISE	SVTYPE	CHR2	END	PE	MAPQ	CT	CIPOS	CIEND	SRMAPQ	INSLEN	HOMLEN	SR	SRQ	CONSENSUS	CE	SV_LENGTH	seqnames	start	end	width	strand	source	type	score	phase	gene_version	gene_source	gene_biotype	transcript_id	transcript_version	transcript_source	transcript_biotype	exon_number	exon_id	exon_version	protein_id	protein_version	gene_name	transcript_name	tag	EGGNOG	ENTRY-NAME	FEATURES	FUNCTION	GENES	GO	UNIPROT_ID	KEGG	KO	LENGTH	PATHWAY	PDB	REVIEWED	SCORE	SEQUENCE	UNIPROTKB
DUP00000067	ENSBTAG00000051169	2	25667155	A	<DUP>	.	PASS	TRUE	DUP	2	25667271	0	0	5to3	-2,2	-2,2	60	0	1	3	1	ATTTGATAGTTCTAAAGGTCAAAAGTGCTTGAAAGGATTATGATTCTCTAAGGATTCCTTCTGATTGGAAATTCTATGTTTGTGGGCCACCAAAAAT	1.91203	116	2	25660200	25694204	34005	-	ensembl	gene	NA	NA	1	ensembl	protein_coding	NA	NA	NA	NA	NA	NA	NA	NA	NA	ERICH2	NA	NA	ENOG502S4MD	ERIC2_BOVIN	Chain (1)	NA	ERICH2	NA	A6QQ66	bta:615113	NA	 142	NA	NA	reviewed	1 out of 5	MSKNVVIAEQEKNNEHCPEDINDKLSESTDDDGEDTSDEDKEEDSNPNKDTHAPLELMTEFLRAEMGHDYHLAKKLCQMILIYEPENPEAKEFFSLIEEMLLMEKAQNLEEDDDESEEDNSESEGESTEDPSEESSDECEDG	A6QQ66
DUP00000303	ENSBTAG00000024888	6	5432986	T	<DUP>	.	PASS	TRUE	DUP	6	5800660	32	60	5to3	-1,1	-1,1	60	0	0	7	0.970238	ACCCTGTACTTATCAGAGAGCTTTGCTAGAACAGCATCCAGCCAGGCTGCAGAGCACGGACCTGTTGTAAGTATAGGTGGTGCCAGTCTGTAATGTTTTTATGTTCAAAGTTTTCTAAAATTGGCACTGTTTAAAATTTAAGACTGAAAACAACAGTAATGTAAGT	1.96248	367674	6	5745779	5894011	148233	+	ensembl	gene	NA	NA	5	ensembl	protein_coding	NA	NA	NA	NA	NA	NA	NA	NA	NA	PDE5A	NA	NA	KOG3689	PDE5A_BOVIN	Active site (1); Binding site (1); Chain (1); Domain (3); Metal binding (5); Modified residue (1); Mutagenesis (7)	FUNCTION: Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP (PubMed:8530505). Specifically regulates nitric-oxide-generated cGMP (By similarity). {ECO:0000250|UniProtKB:O76074, ECO:0000269|PubMed:8530505}.	PDE5A PDE5	3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; signal transduction [GO:0007165]	Q28156	bta:281972	NA	 865	PATHWAY: Purine metabolism; 3',5'-cyclic GMP degradation; GMP from 3',5'-cyclic GMP: step 1/1.	3JBQ	reviewed	5 out of 5	MERAGPGSARPQQQWDQDSVEAWLDDHWDFTFSYFVRKGTREMVNAWFAERVHTIPVCKEGIKGHTESCSCPLQPSPRAESSVPGTPTRKISASEFDRPLRPIVIKDSEGTVSFLSDSDKKEQMPLTSPRFDNDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEASNNCIRLEWNKGIVGHVAAFGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTRERDANRINYMYAQYVKNTMEPLNIPDVSKDKRFPWTNENMGNINQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEETTGKVKAFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCKWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQKRLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIMKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPADLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKTLINGESSQTKRN	Q28156
DUP00000303	ENSBTAG00000024888	6	5432986	T	<DUP>	.	PASS	TRUE	DUP	6	5800660	32	60	5to3	-1,1	-1,1	60	0	0	7	0.970238	ACCCTGTACTTATCAGAGAGCTTTGCTAGAACAGCATCCAGCCAGGCTGCAGAGCACGGACCTGTTGTAAGTATAGGTGGTGCCAGTCTGTAATGTTTTTATGTTCAAAGTTTTCTAAAATTGGCACTGTTTAAAATTTAAGACTGAAAACAACAGTAATGTAAGT	1.96248	367674	6	5745779	5894011	148233	+	ensembl	gene	NA	NA	5	ensembl	protein_coding	NA	NA	NA	NA	NA	NA	NA	NA	NA	PDE5A	NA	NA	KOG3689	PDE5A_BOVIN	Active site (1); Binding site (1); Chain (1); Domain (3); Metal binding (5); Modified residue (1); Mutagenesis (7)	FUNCTION: Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP (PubMed:8530505). Specifically regulates nitric-oxide-generated cGMP (By similarity). {ECO:0000250|UniProtKB:O76074, ECO:0000269|PubMed:8530505}.	PDE5A PDE5	3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; signal transduction [GO:0007165]	Q28156	bta:281972	NA	 865	PATHWAY: Purine metabolism; 3',5'-cyclic GMP degradation; GMP from 3',5'-cyclic GMP: step 1/1.	1FL4	reviewed	5 out of 5	MERAGPGSARPQQQWDQDSVEAWLDDHWDFTFSYFVRKGTREMVNAWFAERVHTIPVCKEGIKGHTESCSCPLQPSPRAESSVPGTPTRKISASEFDRPLRPIVIKDSEGTVSFLSDSDKKEQMPLTSPRFDNDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEASNNCIRLEWNKGIVGHVAAFGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTRERDANRINYMYAQYVKNTMEPLNIPDVSKDKRFPWTNENMGNINQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEETTGKVKAFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCKWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQKRLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIMKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPADLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKTLINGESSQTKRN	Q28156
DUP00000303	ENSBTAG00000024888	6	5432986	T	<DUP>	.	PASS	TRUE	DUP	6	5800660	32	60	5to3	-1,1	-1,1	60	0	0	7	0.970238	ACCCTGTACTTATCAGAGAGCTTTGCTAGAACAGCATCCAGCCAGGCTGCAGAGCACGGACCTGTTGTAAGTATAGGTGGTGCCAGTCTGTAATGTTTTTATGTTCAAAGTTTTCTAAAATTGGCACTGTTTAAAATTTAAGACTGAAAACAACAGTAATGTAAGT	1.96248	367674	6	5745779	5894011	148233	+	ensembl	gene	NA	NA	5	ensembl	protein_coding	NA	NA	NA	NA	NA	NA	NA	NA	NA	PDE5A	NA	NA	KOG3689	PDE5A_BOVIN	Active site (1); Binding site (1); Chain (1); Domain (3); Metal binding (5); Modified residue (1); Mutagenesis (7)	FUNCTION: Plays a role in signal transduction by regulating the intracellular concentration of cyclic nucleotides. This phosphodiesterase catalyzes the specific hydrolysis of cGMP to 5'-GMP (PubMed:8530505). Specifically regulates nitric-oxide-generated cGMP (By similarity). {ECO:0000250|UniProtKB:O76074, ECO:0000269|PubMed:8530505}.	PDE5A PDE5	3',5'-cyclic-GMP phosphodiesterase activity [GO:0047555]; 3',5'-cyclic-nucleotide phosphodiesterase activity [GO:0004114]; cGMP binding [GO:0030553]; cyclic-nucleotide phosphodiesterase activity [GO:0004112]; metal ion binding [GO:0046872]; cGMP catabolic process [GO:0046069]; signal transduction [GO:0007165]	Q28156	bta:281972	NA	 865	PATHWAY: Purine metabolism; 3',5'-cyclic GMP degradation; GMP from 3',5'-cyclic GMP: step 1/1.	3JAB	reviewed	5 out of 5	MERAGPGSARPQQQWDQDSVEAWLDDHWDFTFSYFVRKGTREMVNAWFAERVHTIPVCKEGIKGHTESCSCPLQPSPRAESSVPGTPTRKISASEFDRPLRPIVIKDSEGTVSFLSDSDKKEQMPLTSPRFDNDEGDQCSRLLELVKDISSHLDVTALCHKIFLHIHGLISADRYSLFLVCEDSSNDKFLISRLFDVAEGSTLEEASNNCIRLEWNKGIVGHVAAFGEPLNIKDAYEDPRFNAEVDQITGYKTQSILCMPIKNHREEVVGVAQAINKKSGNGGTFTEKDEKDFAAYLAFCGIVLHNAQLYETSLLENKRNQVLLDLASLIFEEQQSLEVILKKIAATIISFMQVQKCTIFIVDEDCSDSFSSVFHMECEELEKSSDTLTRERDANRINYMYAQYVKNTMEPLNIPDVSKDKRFPWTNENMGNINQQCIRSLLCTPIKNGKKNKVIGVCQLVNKMEETTGKVKAFNRNDEQFLEAFVIFCGLGIQNTQMYEAVERAMAKQMVTLEVLSYHASAAEEETRELQSLAAAVVPSAQTLKITDFSFSDFELSDLETALCTIRMFTDLNLVQNFQMKHEVLCKWILSVKKNYRKNVAYHNWRHAFNTAQCMFAALKAGKIQKRLTDLEILALLIAALSHDLDHRGVNNSYIQRSEHPLAQLYCHSIMEHHHFDQCLMILNSPGNQILSGLSIEEYKTTLKIIKQAILATDLALYIKRRGEFFELIMKNQFNLEDPHQKELFLAMLMTACDLSAITKPWPIQQRIAELVATEFFDQGDRERKELNIEPADLMNREKKNKIPSMQVGFIDAICLQLYEALTHVSEDCFPLLDGCRKNRQKWQALAEQQEKTLINGESSQTKRN	Q28156
DEL00000388	ENSBTAG00000014551	7	34544872	A	<DEL>	.	PASS	TRUE	DEL	7	34545468	0	0	3to5	-11,11	-11,11	60	0	13	3	1	TTTACTGCTGTGAAAATTAATCTTAAAAAGAGATCACAGCTTTTAAAATTGTCTATGGGAAACTCTTTATACTGGTACTCAGCTTCATTTTCTAGAGTCAAAATTAATACCATT	1.86561	596	7	34474474	34609385	134912	-	ensembl	gene	NA	NA	6	ensembl	protein_coding	NA	NA	NA	NA	NA	NA	NA	NA	NA	TNFAIP8	NA	NA	ENOG502S00N	TFIP8_BOVIN	Chain (1); Coiled coil (1)	FUNCTION: Acts as a negative mediator of apoptosis. Suppresses the TNF-mediated apoptosis by inhibiting caspase-8 activity but not the processing of procaspase-8, subsequently resulting in inhibition of BID cleavage and caspase-3 activation (By similarity). {ECO:0000250}.	TNFAIP8	cytoplasm [GO:0005737]; nucleoplasm [GO:0005654]; cysteine-type endopeptidase inhibitor activity involved in apoptotic process [GO:0043027]; positive regulation of apoptotic process [GO:0043065]	A4IF78	bta:529336	NA	 198	NA	NA	reviewed	2 out of 5	MHFEAEESKEVATDVFNSKNLAVQAQKKILGKMASKSIATTLIDDTSSEVLDELYRVTKEYTQNKKEAEKIIKNLIKTVIKLAILYRNNQFNQDELALMEKFKKKVHQLAMTVVSFHQVDFTFDRNVLSKLLNECREMLHQIIQRHLTTKSHGRVNNVFDHFSDCDFLAALYNPFGNYKPHLQKLCDGINKMLDEENI	A4IF78
DEL00000565	ENSBTAG00000025324	10	90810534	A	<DEL>	.	PASS	TRUE	DEL	10	90811404	6	60	3to5	-6,6	-6,6	60	0	5	4	1	GAAGTAGGCTGTGGAAAAAACATGATGTAGTTAGTCATTTCATGGACTCTAGCATGTAATGCGGAGAAGGCAATGGCAGGCCAGTGGTTAGGGCTCCATGCTTTCAGTTCAGGGGGCCAGAGTT	1.95935	870	10	90495258	91099930	604673	+	ensembl	gene	NA	NA	5	ensembl	protein_coding	NA	NA	NA	NA	NA	NA	NA	NA	NA	NRXN3	NA	NA	NA	NRX3B_BOVIN	Alternative sequence (2); Chain (3); Compositional bias (4); Domain (1); Erroneous initiation (1); Glycosylation (3); Signal peptide (1); Topological domain (2); Transmembrane (1)	FUNCTION: Neuronal cell surface protein that may be involved in cell recognition and cell adhesion. May play a role in angiogenesis (By similarity). {ECO:0000250}.	NRXN3	extracellular region [GO:0005576]; integral component of membrane [GO:0016021]; plasma membrane [GO:0005886]; angiogenesis [GO:0001525]; cell adhesion [GO:0007155]	Q28143	NA	NA	 456	NA	NA	reviewed	5 out of 5	MHLRIHARRNPPRRPAWTLGIWSLFWGCIVSSVWSSSNVASSSSSPGSHSQHEHHFHGSKHHSVPISIYRSPVSLRGGHAGATYIFGKSGGLILYTWPANDRPSTRSDRLAVGFSTTVKDGILVRIDSAPGLGDFLQLHIEQGKIGVVFNIGTVDISIKEERTPVNDGKYHVVRFTRNGGNATLQVDNWPVNEHYPTGNTDNERFQMVKQKIPFKYNRPVEEWLQEKGRQLTIFNTQAQIAIGGKDKGRLFQGQLSGLYYDGLKVLNMAAENNPNIKINGSVRLVGEVPSILGTTQTTSMPPEMSTTVMETTTTMATTTTRKNRSTASIQPTSDDLVSSAECSSDDEDFVECEPSTANPTEPGVRRVPGASEVIRESSSTTGMVVGIVAAAALCILILLYAMYKYRNRDEGSYQVDETRNYISNSAQSNGTLLKEKPPSSKGGHKKQKNKDKEYYV	Q28143
DEL00000862	ENSBTAG00000006291	18	19148478	T	<DEL>	.	PASS	TRUE	DEL	18	19149040	0	0	3to5	-3,3	-3,3	60	0	4	3	1	AGTTTCTTGTATATCTTTTTAGAGTTTCTTCATACAGTATAGGTGCATATTCTTTTCTGTGCTCTACAGTAGGACCTTGTTTTTTATCTGTTTTATGTAGTAG	1.79239	562	18	19131365	19199820	68456	+	ensembl	gene	NA	NA	5	ensembl	protein_coding	NA	NA	NA	NA	NA	NA	NA	NA	NA	CYLD	NA	NA	KOG3556	CYLD_BOVIN	Active site (2); Chain (1); Domain (4); Metal binding (8); Modified residue (3); Region (4)	FUNCTION: Deubiquitinase that specifically cleaves 'Lys-63'- and linear 'Met-1'-linked polyubiquitin chains and is involved in NF-kappa-B activation and TNF-alpha-induced necroptosis. Plays an important role in the regulation of pathways leading to NF-kappa-B activation. Contributes to the regulation of cell survival, proliferation and differentiation via its effects on NF-kappa-B activation. Negative regulator of Wnt signaling. Inhibits HDAC6 and thereby promotes acetylation of alpha-tubulin and stabilization of microtubules. Plays a role in the regulation of microtubule dynamics, and thereby contributes to the regulation of cell proliferation, cell polarization, cell migration, and angiogenesis. Required for normal cell cycle progress and normal cytokinesis. Inhibits nuclear translocation of NF-kappa-B. Plays a role in the regulation of inflammation and the innate immune response, via its effects on NF-kappa-B activation (By similarity). Dispensable for the maturation of intrathymic natural killer cells, but required for the continued survival of immature natural killer cells. Negatively regulates TNFRSF11A signaling and osteoclastogenesis. Involved in the regulation of ciliogenesis, allowing ciliary basal bodies to migrate and dock to the plasma membrane; this process does not depend on NF-kappa-B activation (By similarity). Ability to remove linear ('Met-1'-linked) polyubiquitin chains regulates innate immunity and TNF-alpha-induced necroptosis: recruited to the LUBAC complex via interaction with SPATA2 and restricts linear polyubiquitin formation on target proteins. Regulates innate immunity by restricting linear polyubiquitin formation on RIPK2 in response to NOD2 stimulation (By similarity). Involved in TNF-alpha-induced necroptosis by removing linear ('Met-1'-linked) polyubiquitin chains from RIPK1, thereby regulating the kinase activity of RIPK1 (By similarity). Removes 'Lys-63' linked polyubiquitin chain of MAP3K7, which inhibits phosphorylation and blocks downstream activation of the JNK-p38 kinase cascades (By similarity). {ECO:0000250|UniProtKB:Q80TQ2, ECO:0000250|UniProtKB:Q9NQC7}.	CYLD CYLD1	centrosome [GO:0005813]; ciliary basal body [GO:0036064]; ciliary tip [GO:0097542]; cytoplasmic microtubule [GO:0005881]; cytosol [GO:0005829]; extrinsic component of cytoplasmic side of plasma membrane [GO:0031234]; midbody [GO:0030496]; perinuclear region of cytoplasm [GO:0048471]; spindle [GO:0005819]; cysteine-type peptidase activity [GO:0008234]; Lys63-specific deubiquitinase activity [GO:0061578]; proline-rich region binding [GO:0070064]; protein kinase binding [GO:0019901]; thiol-dependent ubiquitin-specific protease activity [GO:0004843]; zinc ion binding [GO:0008270]; innate immune response [GO:0045087]; necroptotic process [GO:0070266]; negative regulation of canonical Wnt signaling pathway [GO:0090090]; negative regulation of JNK cascade [GO:0046329]; negative regulation of NF-kappaB transcription factor activity [GO:0032088]; negative regulation of NIK/NF-kappaB signaling [GO:1901223]; negative regulation of p38MAPK cascade [GO:1903753]; positive regulation of extrinsic apoptotic signaling pathway [GO:2001238]; protein deubiquitination [GO:0016579]; protein K63-linked deubiquitination [GO:0070536]; protein linear deubiquitination [GO:1990108]; regulation of cilium assembly [GO:1902017]; regulation of inflammatory response [GO:0050727]; regulation of intrinsic apoptotic signaling pathway [GO:2001242]; regulation of microtubule cytoskeleton organization [GO:0070507]; regulation of mitotic cell cycle [GO:0007346]; regulation of necroptotic process [GO:0060544]; regulation of tumor necrosis factor-mediated signaling pathway [GO:0010803]; ubiquitin-dependent protein catabolic process [GO:0006511]; Wnt signaling pathway [GO:0016055]	Q1RMU2	bta:536421	NA	 953	NA	NA	reviewed	5 out of 5	MSSGLWSQEKVTSPYWEERIFYLLLQECSVTDKQTQKLLKVPKGSIGQNIQDRSVGLSRIPSAKGKKNQIGLKILEQPHAVLFVDEKDVVEINEKFTELLLAITNCEERFSLFKNRNRLSKGLQIDVGCPVKVQLRSGEEKFPGVVRFRGPLLAERTVSGIFFGVELLEEGRGQGFTDGVYQGKQLFQCDEDCGVFVALDKLELIEDDDTGLESDYAGPVDTMQVELPPLEINSRVSLKLGETIESGTVIFCDVLPGKESLGYFVGVDMDNPIGNWDGRFDGVQLCSFASVESTILLHINDIIPESVTQERRPPKLAFMSRGVGDKGSFSHNKPKATGSTSDPGTRNRSELFYTLNGSSVDSQPQSKSKNSWYIDEVAEDPAKSLTEIPPDFGHASPPLQPPSMNSLSSENRFHSLPFSLTKMPNTNGSISHSPLSLSVQSVMGELNNAPVQESPPLAVSSGNSHGLEVGSLAEVKENPPFYGVIRWIGQPPGLNEVLAGLELEDECAGCTDGTFRGTRYFTCALKKALFVKLKSCRPDSRFASLQPVSNQIERCNSLAFGGYLSEVVEENTPPKMEKEGFEIMIGKKKGIQGHYNSCYLDSTLFCLFAFSSVLDTVLLRPKEKNDVEYYSETQELLRTEIVNPLRIYGYVCATKIMKLRKILEKVEAASGFTSEEKDPEEFLNILFHHILRVEPLLKIRSAGQKVQDCYFYQIFMEKNEKVGVPTIQQLLECSFINSNLKFAEAPSCLIIQMPRFGKDFKLFKKIFPSLELNITDLLEDTPRQCRICGGLAMYECRECYDDPDISAGKIKQFCKTCNAQVHLHPKRLNHKYNPVSLPKDLPDWDWRHGCIPCQKMELFAVLCIETSHYVAFVKYGKDDSAWLFFDSMADRDGGQNGFNIPQVTPCPEVGEYLKMSLDDLHSLDSRRIQGCARRLLCDAYMCMYQSPTMSLYK	Q1RMU2
